Disease Landscape and Forecast Insights
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
Crohn’s Disease | Treatment Algorithms: Claims Data Analysis | Adult | US | 2022
Crohn’s disease (CD) is a chronic inflammatory disorder of the gastrointestinal tract characterized by diarrhea, abdominal pain, and weight loss. The primary goal of CD treatment is to induce and…
Atopic Dermatitis | Emerging Therapies | Eucrisa (crisaborole) | US | Wave 2 | 2017
Atopic Dermatitis | Emerging Therapies | Eucrisa | US is a three-wave series that tracks the introduction of Pfizer’s Eucrisa for the treatment of AD. The series is based on primary research data…
Male Hypogonadism (Low Testosterone) | Niche & Rare Disease Landscape & Forecast | US/EU5
Male hypogonadism is characterized by low serum testosterone and impaired spermatogenesis. Primary male hypogonadism results from an intrinsic abnormality in the testes, while secondary male…
Essential Thrombocythemia | Treatment Algorithms: Claims Data Analysis | US | 2022
Essential thrombocythemia (ET) is a rare chronic myeloproliferative disease characterized by the overproduction of platelets. While the etiology of ET is not fully understood, a genetic mutation…
Graft Versus Host Disease – Epidemiology – Epidemiology – Graft Versus Host Disease – Emerging Markets
Clarivate Epidemiology’s coverage of graft versus host disease (GVHD) comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets and the emerging…
Graft Versus Host Disease – Epidemiology – Epidemiology – Graft Versus Host Disease – Mature Markets
Clarivate Epidemiology’s coverage of graft versus host disease (GVHD) comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets and the emerging…
